register

Best Practice

What makes a fulfilling life? Lessons from the longest study on happiness

Health Industry Hub | May 20, 2020 |
[Total: 1    Average: 5/5]

Robert Waldinger is a psychiatrist and the Director of the Harvard Study of Adult Development. He conducted one of the most comprehensive longitudinal studies in history.

What keeps us happy and healthy as we go through life? If you think it’s fame and money, you’re not alone. In this TED talk, Dr Waldinger compares these common notions to scientific data on the good life gathered from a 75-year-long study of adult development.

He shares three important lessons learned from the study as well as some practical wisdom on how to build a fulfilling life.

Dr. Waldinger is the author of numerous scientific papers as well as two books. He teaches medical students and psychiatry residents at Massachusetts General Hospital in Boston, and he is a Senior Dharma Teacher in Boundless Way Zen.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.


Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]

More


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]

More


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]

More


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]

More